Customer Center
Login | Register


Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

Colorado Lab Uses VERIGENE EP Test to Rapidly Identify Shiga Toxin

Rapid response to infections from a county fair improved patient treatment

This summer, several people contracted Shiga toxin-producing E. coli at the Mesa County Fair in Colorado. Typically, detecting the bacteria and tracing it back to the county fair would take weeks, says Angie Silva, microbiology manager at St. Mary’s Hospital, where the patients were seen.

Visit our blog >

Galapagos, A Luminex Partner

Galapagos, A Luminex Partner


The team from Galapagos NV talks about their Mission to become the largest Biotech company in Europe, and how automating the Luminex FLEXMAP 3D® system is helping with their drug discovery.

Watch more videos >

Luminex on Twitter

Anjana Bhattacharya leads the entire life cycle of Luminex’s #womenshealth product portfolio. #FacesofLuminex
h J R
VERIGENE's rapid #moleculartesting has enabled @StMarys_GJ to generate better results. Learn more:
h J R
We’re hosting two corporate workshops at #AMP2017 this year. Learn more and register:
h J R

Latest News

August 29
Luminex Corporation and Sutter Health Collaborate to Improve Patient Care

August 7
Luminex Corporation Reports Second Quarter 2017 Financial Results

July 24
Luminex Corporation Receives FDA Clearance for ARIES C. difficile Assay

July 17
Luminex Corporation Second Quarter Earnings Release Scheduled for August 7, 2017

June 28
Luminex Corporation Receives CE-IVD Mark for ARIES® Norovirus Assay

June 5
Luminex Corporation’s VERIGENE Gram-Positive and Gram-Negative Blood Culture Panels Receive Reimbursement Approval in Japan


SWACM Annual Meeting
September 6-9
St. Louis, MO

xMAP Connect U.S. 2017
September 19
Boston, MA

Intermountain States Seminar
September 29-30
Jackson, WY

PSI Annual Meeting
October 3
Dublin, OH

October 4-8
San Diego, CA